
Advocacy
HealthHIV brings a re-energized approach to addressing the advocacy agenda in order to improve health disparities, treat the medically underserved, advance chronic disease management, and redefine how HIV fits into a broader health care debate.
HealthHIV leads the National Resource Center for Care Coordination and Pozitively Aging with HIV, which builds the capacity of HIV and primary care providers to coordinate care for people living and aging with HIV across a lifetime. This program enhances provider and patient knowledge related to the experiences of PWH over 50 and the comanagement of conditions associated with aging with HIV through data collection and medical education.
HealthHIV—along with the National Coalition for LGBTQ Health—seeks to better align care and prevention service delivery with existing evidence-based, culturally sensitive standards of care for LGBTQ people to improve health outcomes and qualities of life.
We engage partners across all levels of advocacy, from federal and state-specific issues, to health systems and payers, providers and manufacturers. But most of all, we engage with our communities to drive our work.
Inflation Reduction Act (IRA) Resource Hub
As the Medicare Drug Price Negotiation Program (MDPNP) transforms the prescription drug market, HealthHIV champions the essential needs of patients amid the rollout of negotiated prices for high-cost medications and adjustments by healthcare stakeholders.
Learn MoreIssues in Focus
Browse Issues-
Florida AIDS Drug Assistance Program
A few important developments and action items to share on the Florida ADAP situation.
-
HIV & Aging Issues Brief: January 2026
Welcome to the first HIV & Aging Issues Brief for January of 2026. Below is compiled a series of key public health policy issues and research items pertinent to the ongoing work of HealthHIV and the Coalition—happening both nationally and internationally.
Latest Advocacy Resources
Browse Resources-
National Health Council IPAY 2028 Patient and Provider Toolkit
Overview of IPAY 2028, including an op-ed, written comments, and a communications toolkit.
-
Access Considerations for People Aging with HIV: IRA Negotiations and BIKTARVY®
The Centers for Medicare & Medicaid Services (CMS) recently selected 15 Medicare-covered drugs for the third cycle of Medicare drug price negotiation, known as IPAY 2028, under the Inflation Reduction Act (IRA). BIKTARVY (bictegravir, emtricitabine, and tenofovir alafenamide), a widely used single-tablet HIV treatment regimen, is one of the selected drugs. This fact sheet provides…



